netFormulary NHS
Cambridgeshire and Peterborough
Formulary
 Search
 Results

Looking for Ofatumumab found 10 matches

Formulary BNF Category
  Cytotoxic Drug Restricted Drug  Idelalisib  (Zydelig) Other antineoplastic drugs - 08.01.05
  Restricted Drug  Ofatumumab  (Arzerra)
(Infusion)
Anti-lymphocyte monoclonal antibodies - 08.02.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update December 2014: Ofatumumab - risk of serious and fatal infusion reactions. Always give premedication and monitor carefully.  (08.02.03)
link in drug section MHRA Drug Safety Update December 2014: Ofatumumab - screen for hepatitis B virus before treatment (08.02.03)
link in drug section NICE TA344: Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia.  (08.01.01)
link in drug section NICE TA344: Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia.  (08.01.01)
link in drug section NICE TA344: Ofatumumab with chlorambucil or bendamustine for CLL (08.02.03)
link in drug section NICE TA469 TERMINATED APPRAISAL: Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (08.01.05)
link in drug section NICE TA469 TERMINATED APPRAISAL: Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (08.02.03)
link in drug section NICE TA470 TERMINATED APPRAISAL: Ofatumumab with chemotherapy for treating chronic lymphocytic leukaemia (08.02.03)


 

netFormulary